ABI
IMMU

Adamant Biomedical Investments’s Immunomedics Inc IMMU Stock Holding History

Adamant Biomedical Investments’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$720K Hold
150,000
– – 0.17% 86
2014
Q3 		$558K Buy
+150,000
New +$507K 0.14% 85

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Adamant Biomedical Investments's IMMU Position: Q4 2014 in Review

Adamant Biomedical Investments held its Immunomedics Inc (IMMU) position steady in Q4 2014 at 150,000 shares worth $720K. The position accounts for 0.17% of the portfolio, ranked #86.

Adamant Biomedical Investments first reported a position in IMMU in Q3 2014 and has held it in 2 quarters since. 85 funds tracked by Wall St. Rank hold IMMU as of Q4 2014.

  • Adamant Biomedical Investments held 150,000 shares of Immunomedics Inc worth $720K as of Q4 2014.
  • Adamant Biomedical Investments left its Immunomedics Inc share count unchanged in Q4 2014.
  • Immunomedics Inc made up 0.17% of Adamant Biomedical Investments's portfolio in Q4 2014, its #86 holding.
  • Adamant Biomedical Investments first reported a position in Immunomedics Inc in Q3 2014 and has held it in 2 quarters since.
  • 85 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.